TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 7 Jan 2025, 17:01 GMT

Official UK procurement notice

NP47825 Multiple Sclerosis Medicines

Official notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)

Framework agreement2 lotsGoodsOpen procedure
Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)
Framework ceiling (notional)£51,517,832total for 2 lots · framework ceiling, not attributable revenue
Submissions closed 10 Feb 2025awarded 15 Apr 2025
Lots 2see the lot list below

What is being bought2 lots · detail below

Published requirement description

Supply of multiple sclerosis medicines to NHS Scotland.

CPV: Pharmaceutical products

How this framework works

From the published notice
Places
up to 15 suppliers · 10 bids on the busiest of 2 lots (0.7 per place) · 8 appointed

Lots and requirements (2)Procurement structure

2 lots · all with a published value · same evaluation weights on every lot
Lot #1Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumabCancelledRenewalPublished value£49,317,952

Supply of glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab to NHS Scotland.

The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #2Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsulesCancelledRenewalPublished value£2,199,880

Supply of fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules to NHS Scotland. The Authority has award this Lot as a single supplier Framework Agreement per product line to three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored · same split on all 2 lots
Quality: 5%Price: 95%
Published sub-criteria (2)
  • Technical (Supply Chain): 5%
  • price: 95%
Published award criteria (2)
  • Technical (Supply Chain): 5
  • Price: 95
Conditions of participation2
  • Suitability

    Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015).

  • Technical & professional ability

    (a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender for the Framework Agreement.

    AND

    (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.

    AND

    (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.

    AND

    (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.

    AND

    (e) Potential Framework Participants must be able to demonstrate that all devices tendered and associated ancillaries under this Framework Agreement comply with Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) and have an appropriate declaration of conformity and display a valid CE, CE UKNI or UKCA mark.

    Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualificat…
What this means for your bid
  • Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
  • “NP47825 Multiple Sclerosis Medicines” is a framework: the contest is a place on its panel, up to 15 suppliers, not a single contract.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
7 Jan 2025, 17:01 GMT
Last source update
2 May 2025, 09:05 BST
Award evaluation window
7 Feb 2025 – …
FTS notice number
2025/S 000-018635
Classification (CPV)
Pharmaceutical products
Delivery area
Scotland (UKM)
Official registry OCID
ocds-h6vhtk-04ce06 Find a Tender
Review and risk notes
Review procedure

Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:

An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

Publisher note: The estimated values referred to in Section II.1.7 and Section V.2.4 and within all Lots cover the twenty-seven (27) month contract duration and the twenty-one (21) month extension period of the Framework Agreement. (SC Ref:797683)

How it was run

Official notice
Run through: Public Contracts Scotland · Who buys & how to bid on PCS
Supplier login requiredLanguage: EN
Access & registration note: Free single registration for Scotland; PCS-Tender (Jaggaer) for full bidding
Appointment period ends
10 Feb 2025, 12:00 GMT
Submission channel
{"electronicSubmission"}
Accepted languages
en
Bid validity
90 days from the deadline
Bids opened
7 Feb 2025, 12:00 GMT
Detailed submission instructions & authority contactsFrom official release

www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ↗

Timeline

7 Feb 2025 → 2 May 2025 · 3 dates
  1. Bids opened
    7 Feb 2025, 12:00 GMT
  2. Admission / appointment period endsperiod end, not a bid countdown
    10 Feb 2025, 12:00 GMT
  3. Notice published
    2 May 2025, 09:05 BST

Notice history

2 events · 3 releases on Find a Tender · since 8 Jan 2025
  1. Deadline moved to 10 Feb 2025, 12:00 GMT
    8 Jan 2025, 09:37 GMT
    +3 days · was 7 Feb 2025, 12:00 GMT
  2. Status changed to complete
    2 May 2025, 09:05 BST
Published amendments (1 · 1 deadline change)
WhenWhatBeforeAfterShift
—DeadlineTime limit · IV.2.27 Feb 202510 Feb 2025+3 d
—Bid openingConditions for opening of tenders · IV.2.77 Feb 202510 Feb 2025+3 d

Delay to ITT publish by one (1) day.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 8admitted to the panel · see the list ↓
Bids received 10busiest of 2 lots
Contracts signed 2latest 15 Apr 2025

2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

  • Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules

    Signed
    15 Apr 2025
    Value
    £602,376
    Status
    active

  • Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

    Signed
    9 Apr 2025
    Value
    £47,968,904
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab6bids · 6 electronic · 6 from abroad0——
2 · Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules10bids · 10 electronic · 10 from abroad0——

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authorityNHS & healthcareBody governed by public lawHealth 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact name, email, phone Published organisation website ↗

Dispute resolution & review bodies

  • Sheriff Court HouseReview body EdinburghContact email, phone

Framework contractors & participating bidders

8 commercial parties on the notice
  • Biogen Idec LtdFramework contractor Biogen Building 5 Foundation Park, , Roxborough Way, Maidenhead, Berkshire, England,, Maidenhead, UK, SL6 3UDContact phone
  • Merck Serono LimitedFramework contractor 5 New Square, Bedfont Lakes Business Park , Feltham, Middlesex, London, TW14 8HAContact phone
  • Orifarm UKFramework contractor www.orifarm.com, 10015046, Hemel Hempstead, UK, HP2 4TZContact phone
  • Ranbaxy (UK) LtdFramework contractor Building 4, Chiswick Park, 566 Chiswick High Road, London, UK, W4 5YE
  • STADA UK - Thornton & RossFramework contractor Linthwaite, Huddersfield, UK, HD7 5JNContact phone
  • Sandoz LtdFramework contractor Frimley Business Park, Frimley, Camberley, UK, GU16 7SR
  • Teva UK LtdFramework contractor Ridings Point, Whistler Drive, Glasshoughton, Castleford, UK, WF10 5HXContact phone
  • Viatris UK Healthcare LtdFramework contractor Building 4, Trident Place, Mosquito Way, Hatfield, East of England, AL10 9ULContact phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.